Matt OBrien
Stock Analyst at Piper Sandler
(3.01)
# 1,455
Out of 5,005 analysts
8
Total ratings
87.5%
Success rate
39.77%
Average return
Main Sectors:
Stocks Rated by Matt OBrien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Overweight | $38 | $37.64 | +0.96% | 1 | Sep 2, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $55 → $62 | $84.21 | -26.37% | 6 | Oct 29, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $70 → $90 | $14.71 | +511.83% | 1 | Feb 25, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $37.64
Upside: +0.96%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55 → $62
Current: $84.21
Upside: -26.37%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70 → $90
Current: $14.71
Upside: +511.83%